Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 1, 2023
Emerging Company Profile
Tachyon’s VC round, CIRM grant drive first-in-class oncology program to clinic
Team including Quanticel co-founders has begun Phase I testing of KDM4 program that had traveled through Celgene, BMS
BioCentury | Feb 1, 2018
Translation in Brief
Cloning closer to home
Epigenetic tweaks pave the way for genetically uniform monkey models of disease
Items per page:
1 - 5 of 5